DFX Intelligence

Data Factory

PCI Pharma Services

sponsor (inference, pe portfolio stem): Kohlberg & Company

Search this name across graphsid dfx:pc:b1429780-aedd-5d88-6aa5-3f8630b6be7f

Data as of Jun 30, 2026 (this record's last observation) from The BDC tape; Adviser-reported credit funds; Deal parties; Pending. Page built Sep 19, 2026, 6:42 AM UTC and rebuilt at most every 15 minutes.

Relationships: 1
Dated events: 20
On other graphs: 1
Observed: Mar 31, 2025 to Jun 30, 2026
22 observations

Across DFX

same identity by shared identifier, citation, or a bridge measured by hand

Private Equityidentity

PCI Pharma Services

name equal in sponsor portfolio · confidence 95% · family precision 100%

Facts

fact = as filed or announced; derived = computed by DFX; estimate = a band, never a point

Lenders: 4
BDCs: 4
Facilities: 1
Principal, latest: $183Mpieces as filed; a lower bound
Fair value, latest: $160M
Mark ratio: 120%fair value over cost, latest
Next maturity: Oct 1, 2032
First on a schedule: Mar 31, 2025
Last on a schedule: Jun 30, 2026
Sponsor basis: pe_portfolio_steminferencedeal party is a fact; a portfolio stem or a Form D signer is an inference

Facilities

one facility is one borrower, one kind and one lien; its size is the sum of the BDC pieces the tape can see, a lower bound, never the commitment

Kind	Lien	Size, lower bound	Fair value	Maturity	Maturity basis	Spread	PIK	Lenders	BDCs	Status	Last seen
other	unknown	$183M	$160M	Oct 15, 2032	Html schedule	0	n/a	4	4	Unknown	Jun 30, 2026

Lenders holding it now

each BDC's own pieces on its latest schedule, folded to one row per lender; every amount is that BDC's piece as filed, so a sum is a lower bound; 22 rows folded into 4

BDC	Pieces	Principal	Fair value	Unfunded	Nearest maturity	As of
FS KKR Capital Corp	5	$74.0M	$72.7M	$36.0M	Oct 1, 2032	Jun 30, 2026
KKR Enhanced US Direct Lending Fund-L Inc.	7	$48.3M	$28.2M	$0	Oct 15, 2032	Jun 30, 2026
KKR FS Income Trust	5	$38.2M	$37.5M	$24.6M	n/a	Jun 30, 2026
KKR FS Income Trust Select	5	$22.4M	$22.0M	$15.0M	n/a	Jun 30, 2026

Relationships

Sponsors (1)

← Kohlberg & CompanySponsor of borrowersPE portfolio stem
Sep 13, 2026 to presentinferenceDFX's own graph

Dated events

15 bookkeeping events (roster, classification and holdings changes) folded below

Occurred
Dec 31, 2025
Maturity extended
FS KKR Capital Corp: maturity extended in PCI Pharma Services (2032-07-01 to 2032-10-01)
BDC schedule of investmentsobserved 1 months ago
Occurred
Dec 31, 2025
Maturity extended
KKR Enhanced US Direct Lending Fund-L Inc.: maturity extended in PCI Pharma Services (2032-07-09 to 2032-10-15)
BDC schedule of investmentsobserved 1 months ago
Occurred
Sep 30, 2025
Maturity extended
FS KKR Capital Corp: maturity extended in PCI Pharma Services (2032-01-01 to 2032-07-01)
BDC schedule of investmentsobserved 10 months ago
Occurred
Sep 30, 2025
Maturity extended
KKR Enhanced US Direct Lending Fund-L Inc.: maturity extended in PCI Pharma Services (2032-01-22 to 2032-07-09)
BDC schedule of investmentsobserved 10 months ago
Occurred
Mar 31, 2025
Borrower first appears on a BDC schedule
PCI Pharma Services first appears in a BDC schedule (4 lenders)
FS KKR Capital CorpBDC schedule of investmentsobserved 1.4 years ago
$192M

Show 15 bookkeeping events

Occurred
Jun 30, 2026
KKR FS Income Trust Select: principal decreased in PCI Pharma Services ($22.4M principal)
Occurred
Jun 30, 2026
FS KKR Capital Corp: principal decreased in PCI Pharma Services ($74.0M principal)
Occurred
Jun 30, 2026
KKR FS Income Trust: principal decreased in PCI Pharma Services ($38.2M principal)
Occurred
Jun 30, 2026
KKR Enhanced US Direct Lending Fund-L Inc.: principal decreased in PCI Pharma Services ($48.3M principal)
Occurred
Mar 31, 2026
KKR Enhanced US Direct Lending Fund-L Inc.: principal increased in PCI Pharma Services ($53.0M principal)
Occurred
Dec 31, 2025
KKR FS Income Trust Select: principal increased in PCI Pharma Services ($24.6M principal)
Occurred
Dec 31, 2025
KKR FS Income Trust: principal increased in PCI Pharma Services ($42.0M principal)
Occurred
Dec 31, 2025
KKR Enhanced US Direct Lending Fund-L Inc.: principal increased in PCI Pharma Services ($37.9M principal)
Occurred
Dec 31, 2025
FS KKR Capital Corp: principal increased in PCI Pharma Services ($82.1M principal)
Occurred
Sep 30, 2025
KKR Enhanced US Direct Lending Fund-L Inc.: principal decreased in PCI Pharma Services ($26.9M principal)
Occurred
Jun 30, 2025
FS KKR Capital Corp: principal decreased in PCI Pharma Services ($76.7M principal)
Occurred
Mar 31, 2025
KKR FS Income Trust Select: new position in PCI Pharma Services ($11.0M principal)
Occurred
Mar 31, 2025
KKR FS Income Trust: new position in PCI Pharma Services ($20.0M principal)
Occurred
Mar 31, 2025
FS KKR Capital Corp: new position in PCI Pharma Services ($120.8M principal)
Occurred
Mar 31, 2025
KKR Enhanced US Direct Lending Fund-L Inc.: new position in PCI Pharma Services ($40.0M principal)

Provenance

Graph: Private Credit
Canonical id: dfx:pc:b1429780-aedd-5d88-6aa5-3f8630b6be7f
First observed: Mar 31, 2025
Last observed: Jun 30, 2026 2 months ago
Resolution: Identity across graphs by shared identifier (CRD, CIK, EIN, ADV fund id, individual CRD) or citation; a name match is shown as a candidate and never merged.

PCI Pharma Services

sponsor (inference, pe portfolio stem): Kohlberg & Company

Search this name across graphsid dfx:pc:b1429780-aedd-5d88-6aa5-3f8630b6be7f

Kind

Lien

Size, lower bound

Fair value

Maturity

Maturity basis

Spread

PIK

Lenders

BDCs

Status

Last seen

other

unknown

$183M

$160M

Oct 15, 2032

Html schedule

n/a

Unknown

Jun 30, 2026

BDC

Pieces

Principal

Fair value

Unfunded

Nearest maturity

As of

FS KKR Capital Corp

$74.0M

$72.7M

$36.0M

Oct 1, 2032

Jun 30, 2026

KKR Enhanced US Direct Lending Fund-L Inc.

$48.3M

$28.2M

Oct 15, 2032

Jun 30, 2026

KKR FS Income Trust

$38.2M

$37.5M

$24.6M

n/a

Jun 30, 2026

KKR FS Income Trust Select

$22.4M

$22.0M

$15.0M

n/a

Jun 30, 2026